Publication | Closed Access

A 7-day oral treatment of patients with active rheumatoid arthritis using the prostacyclin analog iloprost: cytokine modulation, safety, and clinical effects

InflammationRheumatologyRheumatoid DisorderAnti-inflammatoryAutoimmune DiseaseMedicineRheumatic DiseasesPharmacologyImmunologyOsteoarthritisProstacyclin Analog IloprostAutoimmunityInflammatory Rheumatic DiseasePharmacotherapyActive Rheumatoid ArthritisCytokine ModulationPsoriatic ArthritisRheumatoid Arthritis